Celiac Disease Is Genetic. Here's Which Genes Control It.

HLA-DQ2 is an immune recognition protein on the surface of your cells that acts as the primary gatekeeper for celiac disease. Its job is to display peptide fragments to your immune system, telling T-cells whether a protein is friend or foe. In people without celiac, HLA-DQ2 presents gluten peptides and the immune system recognizes them as harmless. Your body learns tolerance and moves on.

HLA-DQ2 is carried by approximately 25-30% of people with European ancestry, but only a small fraction of carriers develop celiac disease. The difference lies in other genes and environmental triggers. If you don’t carry HLA-DQ2 (and also don’t carry HLA-DQ8), celiac disease is essentially impossible for you to develop. It is the most common celiac susceptibility variant, found in roughly 90% of people with celiac disease.

When you carry HLA-DQ2, your immune system sees gluten differently. It identifies certain gluten peptides as threats. Your T-cells mobilize. Your intestinal lining becomes a battlefield. The inflammation may or may not cause noticeable symptoms yet, but the intestinal damage can be progressing silently. You might feel bloated, fatigued, brain-fogged, or have no symptoms at all until your gut is severely damaged.

HLA-DQ8 is the second major celiac susceptibility gene, found in roughly 5-10% of people with European ancestry. Like HLA-DQ2, it is an immune recognition protein that presents gluten peptides to your T-cells. It is the second most common celiac variant, present in roughly 10% of people with diagnosed celiac disease.

If you carry HLA-DQ8 but not HLA-DQ2, your celiac risk is lower than HLA-DQ2 carriers but still elevated compared to the general population. HLA-DQ8 activates an immune response to gluten in much the same way as HLA-DQ2, creating the same intestinal attack and barrier damage. The clinical course, symptoms, and recovery timeline are largely identical. The main difference is prevalence: HLA-DQ8 is less common, so fewer people overall develop celiac disease through this pathway.

Your experience with HLA-DQ8 would feel no different from HLA-DQ2 celiac disease. You might notice bloating after bread, chronic diarrhea or constipation, fatigue, brain fog, or dermatitis herpetiformis (an itchy, blistering rash). The intestinal damage would progress the same way, and the treatment is the same: lifelong gluten avoidance.

TNF, or tumor necrosis factor-alpha, is an inflammatory signaling molecule your immune system releases to coordinate an attack on invaders. In controlled amounts, it is essential for clearing infections. Too much, or too chronic, and it becomes destructive. The TNF -308G>A variant affects how much TNF your immune system produces in response to gluten or other gut triggers.

Roughly 30% of the population carries the A allele at position -308 in the TNF gene. People with one or two copies of the A allele tend to produce elevated TNF-alpha, which increases intestinal permeability and deepens gut inflammation. This variant doesn’t cause celiac disease on its own, but if you carry HLA-DQ2 or HLA-DQ8 plus the TNF A allele, your intestinal damage will likely be more severe. Your gut barrier will become more permeable. Your inflammation will be more pronounced.

You’ll notice this as worse bloating, more severe diarrhea or constipation, more pronounced brain fog after gluten exposure, and slower recovery after accidental exposure. Joint pain, skin rashes, and systemic fatigue may accompany your gut symptoms because TNF is a whole-body inflammatory molecule.

IL6, interleukin-6, is another immune signaling molecule that amplifies inflammation and T-cell activation. Where TNF triggers the initial inflammatory burst, IL6 sustains and amplifies it. The IL6 gene has several common variants that affect how much IL6 your immune system produces in response to a threat.

Roughly 30% of the population carries variants that increase IL6 production. People with IL6 variants that increase production mount a more aggressive immune response to gluten and other food antigens, prolonging inflammation and delaying gut healing. The combination of HLA-DQ2 plus high-IL6 variants creates a more severe celiac response than either gene alone.

You’ll experience this as prolonged symptoms after gluten exposure, slower recovery even after complete gluten elimination, and more severe systemic inflammation. Joint pain, mood symptoms, persistent fatigue, and brain fog may linger long after your gut heals because IL6 is a systemic inflammatory signal. You may find that a single gluten exposure triggers a week-long inflammatory cascade.

FUT2 is a fucosyltransferase enzyme that adds fucose sugars to the surface of cells in your gut and other tissues. This seemingly small biochemical task has enormous consequences: it determines what your gut lining looks like to microbes, which microbes can colonize your gut, and whether you can absorb B12 properly.

Roughly 20% of the population are FUT2 non-secretors (rs601338 A/A genotype), meaning they do not express the blood group antigens on their gut cells. Non-secretors have dramatically different gut microbiome compositions compared to secretors, with reduced microbial diversity and fewer protective bacteria. They are more susceptible to norovirus and other pathogens, and they absorb B12 less efficiently from food sources.

If you’re a FUT2 non-secretor and you carry HLA-DQ2 or HLA-DQ8, your microbiome is less equipped to tolerate gluten or maintain a healthy intestinal barrier. You’re more likely to develop leaky gut, more prone to secondary food sensitivities, more likely to develop nutritional deficiencies (especially B12), and you experience worse celiac symptoms. You may notice persistent fatigue, brain fog, tingling in your extremities (B12 deficiency), and slower recovery even after eliminating gluten.

LCT, the lactase gene, controls whether your intestines continue producing lactase enzyme after childhood. Lactase breaks down lactose, the sugar in milk. Most mammals stop producing lactase after weaning, but some humans continue throughout life due to a variant in the LCT gene.

Roughly 65% of the global population and 30% of those with European ancestry have the C/C genotype at rs4988235, meaning they are lactase non-persistent. Your intestines gradually reduce lactase production after childhood, making it progressively harder to digest dairy products. By adulthood, consuming lactose causes bloating, gas, diarrhea, or constipation because the undigested lactose draws water into your intestines and feeds gas-producing bacteria.

If you have celiac disease and you’re lactase non-persistent, you have two separate reasons to avoid conventional dairy. The gluten damage your intestines suffered makes it even harder to digest lactose. Many people with active celiac disease develop temporary secondary lactose intolerance because the damaged intestinal lining cannot produce enough lactase. As your gut heals after gluten elimination, lactose tolerance sometimes returns. But if you’re genetically non-persistent, it will not. You’ll need to choose lactose-free dairy, fermented dairy (yogurt, cheese, kefir) where bacteria have already broken down lactose, or plant-based alternatives.